Your browser doesn't support javascript.
loading
Transcriptomic Profiling of the Tumor Microenvironment Reveals Distinct Subgroups of Clear Cell Renal Cell Cancer: Data from a Randomized Phase III Trial.
Hakimi, A Ari; Voss, Martin H; Kuo, Fengshen; Sanchez, Alejandro; Liu, Ming; Nixon, Briana G; Vuong, Lynda; Ostrovnaya, Irina; Chen, Ying-Bei; Reuter, Victor; Riaz, Nadeem; Cheng, Yuan; Patel, Parul; Marker, Mahtab; Reising, Albert; Li, Ming O; Chan, Timothy A; Motzer, Robert J.
Afiliación
  • Hakimi AA; Department of Urology, Memorial Sloan Kettering Cancer Center, New York, New York. hakimia@mskcc.org vossm@mskcc.org chant@mskcc.org.
  • Voss MH; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. hakimia@mskcc.org vossm@mskcc.org chant@mskcc.org.
  • Kuo F; Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Sanchez A; Department of Urology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Liu M; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Nixon BG; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Vuong L; Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Ostrovnaya I; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Chen YB; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Reuter V; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Riaz N; Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Cheng Y; Novartis Oncology, New York, New York.
  • Patel P; Novartis Oncology, New York, New York.
  • Marker M; Novartis Oncology, New York, New York.
  • Reising A; Novartis Oncology, New York, New York.
  • Li MO; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Chan TA; Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering Cancer Center, New York, New York. hakimia@mskcc.org vossm@mskcc.org chant@mskcc.org.
  • Motzer RJ; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
Cancer Discov ; 9(4): 510-525, 2019 04.
Article en En | MEDLINE | ID: mdl-30622105

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Perfilación de la Expresión Génica / Neoplasias Renales Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Female / Humans / Male Idioma: En Revista: Cancer Discov Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Perfilación de la Expresión Génica / Neoplasias Renales Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Female / Humans / Male Idioma: En Revista: Cancer Discov Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos